Document Detail

Renal interstitial fluid ATP responses to arterial pressure and tubuloglomerular feedback activation during calcium channel blockade.
MedLine Citation:
PMID:  16214849     Owner:  NLM     Status:  MEDLINE    
A close relationship between changes in renal interstitial fluid (RIF) ATP concentrations and renal autoregulatory or tubuloglomerular feedback (TGF)-dependent changes in renal vascular resistance (RVR) has been demonstrated, but it has not been determined whether the changes in RIF ATP are a consequence or the cause of the changes in RVR. The present study was performed in anesthetized dogs to assess the changes in RIF ATP following changes in renal arterial pressure (RAP) or stimulation of the TGF mechanism under conditions where changes in RVR were prevented by nifedipine, a calcium channel blocker. RIF ATP levels were measured by using microdialysis probes. Intra-arterial infusion of nifedipine (0.36 microg x kg(-1) x min(-1)) increased renal blood flow (RBF: from 4.49 +/- 0.27 to 5.34 +/- 0.39 ml x min(-1) x g(-1)) and glomerular filtration rate (GFR: from 0.84 +/- 0.07 to 1.09 +/- 0.11 ml x min(-1) x g(-1)). Under conditions of nifedipine infusion, autoregulatory adjustments in RBF, GFR, and RVR were not observed during stepwise reductions in RAP within the autoregulatory range (from 135 +/- 7 to 76 +/- 1 mmHg, n = 7). Furthermore, stimulation of the TGF mechanism with intra-arterial infusion of acetazolamide (100 microg x kg(-1) x min(-1)) did not alter RBF, GFR, and RVR (n = 7). During treatment with nifedipine, RIF ATP levels were significantly decreased in response to reductions in RAP (10.7 +/- 0.7, 5.8 +/- 0.7 and 2.8 +/- 0.3 nmol/l at 135 +/- 7, 101 +/- 4, and 76 +/- 1 mmHg, n = 7) and increased by acetazolamide infusion (from 8.8 +/- 0.8 to 17.0 +/- 1.8 nmol/l, n = 7). These results are similar to those that occurred in dogs not treated with nifedipine and thus demonstrate that the changes in RIF ATP can occur in the absence of autoregulatory or TGF-mediated changes in RVR. The data provide further support to the hypothesis that RIF ATP contributes to adjustments in RVR associated with renal autoregulation and changes in activity of the TGF mechanism.
Akira Nishiyama; Keith E Jackson; Dewan S A Majid; Matlubur Rahman; L Gabriel Navar
Related Documents :
2480849 - Functional and metabolic effects of ribose in combination with prazosin, verapamil and ...
7852749 - Within-patient correlation between the antihypertensive effects of atenolol, lisinopril...
2751849 - Cardiac and hemodynamic adjustments to rapid and sustained blood pressure reduction.
2216229 - Single dose of nifedipine in normotensive pregnancy: nifedipine concentrations, hemodyn...
7225259 - Nifedipine and left ventricular function in beta-blocked patients.
25200559 - Effects of gastric bypass surgery in patients with hypertension: rationale and design f...
19193889 - Odor-evoked oxygen consumption by action potential and synaptic transmission in the olf...
10926629 - Effects of inspiratory flow on diaphragmatic motor output in normal subjects.
4825239 - Nephron stop-flow pressure response to obstruction for 24 hours in the rat kidney.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2005-10-07
Journal Detail:
Title:  American journal of physiology. Heart and circulatory physiology     Volume:  290     ISSN:  0363-6135     ISO Abbreviation:  Am. J. Physiol. Heart Circ. Physiol.     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-01-11     Completed Date:  2006-02-28     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  100901228     Medline TA:  Am J Physiol Heart Circ Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  H772-7     Citation Subset:  IM    
Department of Physiology, Tulane University Health Sciences Center, New Orleans, Louisiana, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenosine Triphosphate / metabolism*
Blood Pressure / drug effects,  physiology*
Calcium Channel Blockers / pharmacology*
Extracellular Fluid / metabolism*
Feedback, Physiological
Kidney / metabolism*
Kidney Glomerulus / physiology*
Kidney Tubules / physiology*
Nifedipine / pharmacology
Osmolar Concentration
Renal Artery / drug effects,  physiology
Vascular Resistance / physiology
Grant Support
Reg. No./Substance:
0/Calcium Channel Blockers; 21829-25-4/Nifedipine; 56-65-5/Adenosine Triphosphate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Optical mapping of late myocardial infarction in rats.
Next Document:  Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucle...